This is the third competing renewal application for a training program whose main goal is to promote the interdisciplinary training of graduate students in Pharmacological Sciences. Its secondary goal is to foster broader scientific and social interactions among faculty and students in the Pharmacological Sciences. As evidence of the interdisciplinary nature of this program, our trainees come from six departments and four interdepartmental graduate programs in three colleges. The recruitment of 37 trainees with strong-to- outstanding credentials from outside the Department of Pharmacology (of a total of 50) is tangible evidence that this TG functions as a highly effective mechanism to attract the interest and promote the interdisciplinary training of graduate students in the Pharmacological Sciences regardless of departmental affiliation. The TG curriculum provides both basic and advanced instruction in Pharmacological Sciences, and is undergoing continual review and revision to ensure that it fulfills the needs of the program and the students. Its core course sequence, Principles of Pharmacology and Pharmacogenetics & Pharmacogenomics, exposes trainees to the fundamental principles of drug action, and molecular and cellular mechanisms of action of major drug classes. The flagship course of this program, Advanced Problem Solving in Pharmacological Sciences provides trainees multiple opportunities to work as a team to design collaborative research plans, thereby honing their ability to communicate scientific ideas and generate workable solutions to contemporary problems in the Pharmacological Sciences. Two modules are new to the curriculum. Basic Biostatistics and Experimental Design is the program's response to NIH's call for enhanced rigor and reproducibility in science. Science Communication in the Digital Age and the associated workshop Careers outside the Academy: Science Communication broaden the delivery of career skills to better prepare our trainees for the job market. Symposia, a bi-annual retreat, a series of summer-time brown bag discussion luncheons, as well as semi- weekly interactions during Pharmacology Seminar further promote program identity and collaborations. This TG has led to a documented increase in the teaching, mentoring and research interactions among program faculty and their students. With the continued expansion of our research infrastructure, an adaptive curriculum that includes skill building for non-academic careers, and a strong institutional and programmatic commitment to STEM education for minorities, the program is strongly positioned to qualify for an additional five years of funding. Because we typically have more than twice the number of highly qualified applicants than available slots and because our institution is underserved with training grant support, we are requesting an increase in the number of positions from 6 to 7. This modest expansion of our TG is justified by 1) the quality and size of our applicant pool, 2) the diversity of our trainee pool (24% URMs, 48% women), and most importantly, 3) the productivity and success of our graduates.

Public Health Relevance

The Training Grant in Pharmacological Sciences has two main goals, to promote the interdisciplinary training of graduate students in Pharmacological Sciences and to foster interactions among faculty and students from different departments and colleges at the University of Iowa that share an interest in Pharmacological Sciences.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM067795-17
Application #
9962416
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Koduri, Sailaja
Project Start
2004-07-01
Project End
2022-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
17
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Iowa
Department
Pharmacology
Type
Schools of Medicine
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Anderson, Ethan J; Vistoli, Giulio; Katunga, Lalage A et al. (2018) A carnosine analog mitigates metabolic disorders of obesity by reducing carbonyl stress. J Clin Invest 128:5280-5293
Brouillette, Rachel B; Phillips, Elisabeth K; Patel, Radhika et al. (2018) TIM-1 Mediates Dystroglycan-Independent Entry of Lassa Virus. J Virol 92:
White, Katherine A; Swier, Vicki J; Cain, Jacob T et al. (2018) A porcine model of neurofibromatosis type 1 that mimics the human disease. JCI Insight 3:
Riordan, Jesse D; Feddersen, Charlotte R; Tschida, Barbara R et al. (2018) Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice. Hepatology 67:924-939
Rogers, Kai J; Maury, Wendy (2018) The role of mononuclear phagocytes in Ebola virus infection. J Leukoc Biol 104:717-727
Oppegard, Lisa M; Delgado, Justine L; Kulkarni, Chaitanya A et al. (2018) Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity. Invest New Drugs :
Sandgren, Jeremy A; Deng, Guorui; Linggonegoro, Danny W et al. (2018) Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice. JCI Insight 3:
Towle, Tyrell R; Kulkarni, Chaitanya A; Oppegard, Lisa M et al. (2018) Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: Probing for binding contact with the active site tyrosine of gyrase. Bioorg Med Chem Lett 28:1903-1910
Hayes, Michael P; Bodle, Christopher R; Roman, David L (2018) Evaluation of the Selectivity and Cysteine Dependence of Inhibitors across the Regulator of G Protein-Signaling Family. Mol Pharmacol 93:25-35
Nelson, Margaret-Ann M; Builta, Zachariah J; Monroe, T Blake et al. (2018) Biochemical characterization of the catecholaldehyde reactivity of L-carnosine and its therapeutic potential in human myocardium. Amino Acids :

Showing the most recent 10 out of 126 publications